ArticleOncotarget2012

A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma.

Francesco Sottile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.